These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2904048)

  • 21. The management of cirrhotic ascites.
    Yeung E; Wong FS
    MedGenMed; 2002 Oct; 4(4):8. PubMed ID: 12817204
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of a new diuretic, 3-bendroflumethiazide, and chlorothiazide in cirrhotic patients with ascites].
    de ANDRADE D; CAMPANA AO; NEVES DP
    Rev Assoc Med Bras; 1961 Jun; 7():196-202. PubMed ID: 13861358
    [No Abstract]   [Full Text] [Related]  

  • 24. Autogenous ascitic fluid infusion for cirrhotic ascites.
    Sivashanmugam R; Gopalan V; Radhakrishnan AR; Bhaskar N; Ramamurthy A; Prasad PV
    J Indian Med Assoc; 1982 Feb; 78(4):66-9. PubMed ID: 7108244
    [No Abstract]   [Full Text] [Related]  

  • 25. [New experiences on treatment of ascites in the Morgagni-Laënnec cirrhosis by means of reinfusion of autogenous ascitic fluid].
    Barlattani M; Alessandrini A; Vecchi L
    Clin Ter; 1965 Aug; 34(3):210-28. PubMed ID: 5849857
    [No Abstract]   [Full Text] [Related]  

  • 26. Will enhanced salt restriction (invisible sodium only) prolong survival in cirrhosis of liver with ascites?
    Desai HG
    Natl Med J India; 2011; 24(6):377-8. PubMed ID: 22680271
    [No Abstract]   [Full Text] [Related]  

  • 27. [Findings and prospects of concentration-reinfusion treatment in the therapy of the ascites from liver cirrhosis].
    Testa R; Michetti P; Picciotto A; Dellepiane F; Canepa A; Savarino V; Mansi C; De Conca V; Dodero M; Celle G
    Minerva Dietol Gastroenterol; 1979; 25(4):407-12. PubMed ID: 554031
    [No Abstract]   [Full Text] [Related]  

  • 28. TIPS in refractory ascites in cirrhosis: not only survival is the clue.
    Ockenga J; Schuetz T; Lochs H
    Gastroenterology; 2003 Sep; 125(3):997-8. PubMed ID: 12974267
    [No Abstract]   [Full Text] [Related]  

  • 29. Concentration-reinfusion (CR) of ascitic of ascitic fluid in the treatment of decompensated liver cirrhosis with diuretic-resistant ascites.
    Ventura E; Zeneroli ML
    Postgrad Med J; 1975 Aug; 51(598):577-80. PubMed ID: 1234346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of 30 cases of ascitic cirrhosis with spirolactone. Clinical and biological studies].
    VESIN P; GIBOUDEAU ; RENAULT H; CATTAN R
    Bull Mem Soc Med Hop Paris; 1960 Oct 14-21; 76():997-1005. PubMed ID: 13781052
    [No Abstract]   [Full Text] [Related]  

  • 31. [National survey on the treatment of cirrhotic ascites (ENTAC)].
    Descos L; Gauthier A; Levy VG; Michel H; Quinton A; Rueff B; Durbec JP; Fermanian J; Fombone E
    Nouv Presse Med; 1979 Jun; 8(27):2289-91. PubMed ID: 493010
    [No Abstract]   [Full Text] [Related]  

  • 32. In reference to "Use of paracentesis in hospitalized patients with decompensated cirrhosis and ascites: Opportunities for quality improvement".
    Soni NJ; Franco-Sadud R
    J Hosp Med; 2015 May; 10(5):342. PubMed ID: 25755199
    [No Abstract]   [Full Text] [Related]  

  • 33. [TIPS is a life-prolonging treatment of those cirrhosis patients with ascites who can not be treated medically or with paracentesis].
    Aalykke C; Tønner-Nielsen D; Vilstrup H
    Ugeskr Laeger; 2005 Oct; 167(44):4197; author reply 4198-9. PubMed ID: 16266584
    [No Abstract]   [Full Text] [Related]  

  • 34. Ascites reinfusion dialysis of refractory ascites as a bridge to kidney and liver transplantation in a patient on hemodialysis.
    Chang KY; Kim HW; Jin DC; Kim YS
    Korean J Intern Med; 2017 Mar; 32(2):363-364. PubMed ID: 26782038
    [No Abstract]   [Full Text] [Related]  

  • 35. [Refractory ascites?].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1990; 84(24):1239. PubMed ID: 2091395
    [No Abstract]   [Full Text] [Related]  

  • 36. TIPS versus paracentesis for the treatment of refractory ascites.
    Lau A; Bay C; Nadir A
    Hepatology; 2004 Dec; 40(6):1476; author reply 1476-7. PubMed ID: 15565609
    [No Abstract]   [Full Text] [Related]  

  • 37. [2 Non alcoholic cirrhotic ascites cured with cortisone and metacortandracin].
    CORCOS A; CORCOS S; LEVI-ABEGNOLI J
    Bull Mem Soc Med Hop Paris; 1956; 72(27-28):915-8. PubMed ID: 13396598
    [No Abstract]   [Full Text] [Related]  

  • 38. [Old method reevaluated. Paracentesis is effective and safe in the treatment of ascites in patients with liver cirrhosis].
    Johansson A; Eriksson LS
    Lakartidningen; 1992 Jul; 89(28-29):2447-50. PubMed ID: 1507965
    [No Abstract]   [Full Text] [Related]  

  • 39. A controlled double-blind evaluation of hydroflumethiazide and hydrochlorothiazide.
    EDELSTEIN SG; FLESCHER R; MORRISON RS; SHEPS MC; HOWARD FA; CHALMERS TC
    N Engl J Med; 1961 Feb; 264():207-10. PubMed ID: 13725676
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of hepatic cirrhosis ascites by reinfusion of concentrated ascitic fluid using artificial kidney ultrafiltration (author's transl)].
    Chen CY
    Zhonghua Nei Ke Za Zhi; 1979; 18(5):374-6. PubMed ID: 555943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.